174 related articles for article (PubMed ID: 3889175)
21. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
22. Passive immunotherapy in neonatal calves--I. Safety and potency of a J5 Escherichia coli hyperimmune plasma in neonatal calves.
Selim SA; Cullor JS; Oelsner IE
Vaccine; 1995; 13(15):1449-53. PubMed ID: 8578825
[TBL] [Abstract][Full Text] [Related]
23. The role of heparin in guinea pig gram negative bacterial sepsis.
Dunn DL; Mach PA; Cerra FB; Ferguson RM
J Surg Res; 1983 May; 34(5):479-85. PubMed ID: 6405100
[TBL] [Abstract][Full Text] [Related]
24. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
[TBL] [Abstract][Full Text] [Related]
25. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
[TBL] [Abstract][Full Text] [Related]
26. Metabolic effects of pretreatment with Escherichia coli J5 antiserum on guinea pig gram-negative bacterial sepsis.
Dunn DL; Mach PA; Dalmasso AP; Ferguson RM; Cerra FB
J Surg Res; 1985 Mar; 38(3):298-304. PubMed ID: 3884902
[TBL] [Abstract][Full Text] [Related]
27. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
Johns M; Skehill A; McCabe WR
J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
[TBL] [Abstract][Full Text] [Related]
28. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
[TBL] [Abstract][Full Text] [Related]
29. [Effect of immunization with Escherichia coli J5 on the course of experimental pyelonephritis in rats].
Straube E; Naumann G; Broschewitz U
Z Urol Nephrol; 1988 Apr; 81(4):247-55. PubMed ID: 3041706
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria.
de Jongh-Leuvenink J; Bouter AS; Marcelis JH; Schellekens J; Verhoef J
Eur J Clin Microbiol; 1986 Apr; 5(2):148-51. PubMed ID: 2424754
[TBL] [Abstract][Full Text] [Related]
31. Immunization against nosocomial infection.
Braude AI; Ziegler EJ; McCutchan JA; Douglas H
Am J Med; 1981 Feb; 70(2):463-6. PubMed ID: 7008592
[TBL] [Abstract][Full Text] [Related]
32. Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia.
Peter G; Chernow M; Keating MH; Ryff JC; Zinner SH
Infection; 1982; 10(4):228-32. PubMed ID: 6752035
[TBL] [Abstract][Full Text] [Related]
33. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
Braude AI; Ziegler EJ; Douglas H; McCutchan JA
J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.
Fenwick BW; Cullor JS; Osburn BI; Olander HJ
Infect Immun; 1986 Aug; 53(2):298-304. PubMed ID: 3525407
[TBL] [Abstract][Full Text] [Related]
35. Antigenic homology among gram-negative organisms isolated from cattle with clinical mastitis.
Tyler J; Spears H; Cullor J; Smith W; Nelson R; Martin J
J Dairy Sci; 1991 Apr; 74(4):1235-42. PubMed ID: 1907303
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
Siber GR; Kania SA; Warren HS
J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
[TBL] [Abstract][Full Text] [Related]
37. Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide.
Dale PA; McQuillen DP; Gulati S; Rice PA
J Infect Dis; 1992 Aug; 166(2):316-25. PubMed ID: 1378871
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.
Bogard WC; Dunn DL; Abernethy K; Kilgarriff C; Kung PC
Infect Immun; 1987 Apr; 55(4):899-908. PubMed ID: 3549565
[TBL] [Abstract][Full Text] [Related]
39. Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis.
Hogan JS; Weiss WP; Smith KL; Todhunter DA; Schoenberger PS; Sordillo LM
J Dairy Sci; 1995 Feb; 78(2):285-90. PubMed ID: 7745148
[TBL] [Abstract][Full Text] [Related]
40. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
